FrancophonIA/ELRC3.0 huggingface dataset:
English: Patients and carers should be made aware of the behavioural symptoms of impulse control disorders that were observed in patients treated with rasagiline, including cases of compulsions, obsessive thoughts, pathological gambling, increased libido, hypersexuality, impulsive behaviour and compulsive spending or buying.
Maltese: Il-pazjenti u min jieħu ħsiebhom għandhom ikunu konxji tas-sintomi tal-imġiba tad-disturbi fil-kontroll tal-impuls li kienu osservati f'pazjenti kkurati b'rasagiline, inklużi każijiet ta' kompulsjonijiet, ħsibijiet ossessivi, logħob tal-ażżard patoloġiku, żieda fil-libido, ipersesswalità, imġiba impulsiva u nfiq ta' flus jew xiri kompulsiv.
English: Do not take the following medicines while taking Rasagiline ratiopharm: - Monoamine oxidase (MAO) inhibitors (e.g. for treatment of depression or Parkinson's disease, or used for any other indication), including medicinal and natural products without prescription e.g.
Maltese: Parkinson jew għall-użu ta' xi indikazzjoni oħra), inklużi prodotti mediċinali u naturali mingħajr riċetta eż.
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Teva B.V.
Maltese: Tista' wkoll tirrapporta effetti sekondarji direttament permezz tas-sistema ta' rappurtar nazzjonali mniżżla f'Appendiċi V.
English: In blinded placebo-controlled studies, severe orthostatic hypotension was reported in one subject (0.3%) in the rasagiline arm (adjunct studies), none in the placebo arm. Clinical trial data further suggest that orthostatic hypotension occurs most frequently in the first two months of rasagiline treatment and tends to decrease over time.
Maltese: Fi studji blinded ikkontrollati bil-plaċebo, pressjoni ortostatika baxxa severa kienet irrappurtata f'individwu wieħed (0.3%) fil-grupp ta' rasagiline (studji addizzjonali), u fl-ebda individwu fil-grupp tal-plaċebo.
English: Therefore, in view of the MAO inhibitory activity of rasagiline, concomitant administration of rasagiline and sympathomimetics such as those present in nasal and oral decongestants or cold medicinal products, containing ephedrine or pseudoephedrine, is not recommended (see section 4.4).
Maltese: Għaldaqstant, minħabba l-attivita` inibitorja ta' rasagiline għal MAO, mhuwiex rikkmandat l-użu ta' rasagiline flimkien ma' simpatomimetiċi bħal dawk preżenti f'dekonġestjonanti tal-imnieħer u dawk orali jew prodotti mediċinali kontra l-irjiħat li fihom ephedrine jew pseudoephedrine (ara sezzjoni 4.4).
English: Pliva Ljubljana d.o.o.
Maltese: STRUZZJONIJIET DWAR L-UŻU
English: Overdose can be associated with significant inhibition of both MAO-A and MAO-B.
Maltese: Doża eċċessiva tista' tkun assoċjata ma' inibizzjoni sinifikanti ta' kemm MAO-A u MAO-B.
English: Package leaflet 4 - Possible side effects Other side effects:
Maltese: Fuljett ta' tagħrif 4 - Effetti sekondarji possibbli Effetti sekondarji oħra:
English: Leflunomide; teriflunomide - Falsely decreased ionised calcium levels (EPITT no 18787)
Maltese: 2. Leflunomid; teriflunomid - Tnaqqis falz fil-livelli ta ' kalċju jonizzat (EPITT nru 18787)
English: Adopted at the 3-6 April 2017 PRAC
Maltese: Adottati fil-PRAC ta' bejn il-3 u l-6 ta' April 2017
English: Albiglutide - Acute kidney injury (EPITT no 18778)
Maltese: Albiglutid - Ħsara akuta fil-kliewi (EPITT nru 18778)
English: Frequency ‘uncommon': Meningoencephalitis herpetic (including cases with fatal outcome)
Maltese: Frekwenza ‘mhux komuni': Meningoenċefalite ħerpetika (inklużi każijiet b'eżitu fatali)
English: Dehydration, sometimes leading to renal impairment and acute renal failure, has been reported in patients treated with albiglutide and has occurred in patients without gastrointestinal side effects.
Maltese: Deidrazzjoni, li xi drabi twassal għal indeboliment tal-kliewi u insuffiċjenza tal-kliewi akuta, kienet irrapportata f'pazjenti kkurati b'albiglutide u seħħet f'pazjenti mingħajr effetti sekondarji gastrointestinali.
English: The measurement of ionised calcium levels might show falsely decreased values under treatment with leflunomide and/or teriflunomide (the active metabolite of leflunomide) depending on the type of ionised calcium analyser used (e.g. blood gas analyser).
Maltese: Il-kejl tal-livelli ta' kalċju jonizzat jista' juri tnaqqis falz fil-valuri taħt il-kura b'leflunomid u/jew teriflunomid (il-metabolit attiv ta' leflunomid) skont it-tip ta' analizzatur ta' kalċju jonizzat użat (pereżempju analizzatur bil-gass tad-demm).
English: Interference with determination of ionised calcium levels
Maltese: Interferenza b'determinazzjoni ta' livelli ta' kalċju jonizzat
English: Temozolomide - Meningoencephalitis herpetic (EPITT no
Maltese: 3. Temozolomid - Meningoenċefalite ħerpetika (EPITT nru
English: New or reactivated (recurring) cytomegalovirus infections and reactivated hepatitis B virus infections have been uncommonly reported.
Maltese: Infezzjonijiet ċitomegalovirus ġodda jew riattivati (li jerġgħu jitfaċċaw) u infezzjonijiet bil-virus talepatite B riattivat ġew irrapportati b'mod mhux komuni.
English: It is important to avoid dehydration by drinking plenty of fluids.
Maltese: Huwa importanti li tevita deidrazzjoni billi tixrob ħafna fluwidi.
English: Meningoencephalitis herpetic
Maltese: 4.8 - Effetti mhux mixtieqa
English: When initiating treatment with albiglutide, you may experience fluid loss from vomiting, nausea, diarrhoea or dehydration.
Maltese: Meta tibda l-kura b'albiglutid, tista' tesperjenza telf ta' fluwidu permezz ta' remettar, nawżja, dijarea jew deidrazzjoni.
English: In case of doubtful measurements, it is recommended to determine the total albumin adjusted serum calcium concentration.
Maltese: F'każ ta' kejl dubjuż, huwa rakkomandat li tiġi determinata l-konċentrazzjoni totali tal-kalċju fis-serum aġġustat għall-albumina.
English: Cases of brain infections caused by herpes virus (meningoencephalitis herpetic), including fatal cases, have been uncommonly reported.
Maltese: Każijiet ta' infezzjonijiet fil-moħħ ikkawżati mill-virus ħerpes (meningoenċefalite ħerpetika), inklużi każijiet fatali, ġew irrapportati b'mod mhux komuni.
English: Patients treated with albiglutide should be advised of the potential risk of dehydration, and take precautions to avoid fluid depletion.
Maltese: Il-pazjenti kkurati b'albiglutid għandhom jiġu avżati dwar ir-riskju potenzjali ta' deidrazzjoni, u għandhom jieħdu l-prekawzjonijiet biex jiġi evitat tnaqqis ta' fluwidu.
English: New product information wording - Extracts from PRAC recommendations on signals
Maltese: Formulazzjoni ġdida tal-informazzjoni dwar il-prodottSiltiet mir-rakkomandazzjonijiet tal-PRAC dwar is-sinjali
English: In post marketing cases, meningoencephalitis herpetic (including fatal cases) has been observed in patients receiving TMZ in combination with radiotherapy, including cases of concomitant steroids administration.
Maltese: F'każijiet ta' wara t-tqegħid fis-suq, kienet osservata meningoenċefalite ħerpetika (inklużi każijiet fatali) f'pazjenti li kienu qed jingħataw TMZ f'kombinazzjoni ma' radjuterapija, inklużi każijiet ta' għoti konkomitanti ta' sterojdi.
English: Purevax Rabies is a vaccine that contains rabies recombinant canarypox virus (vCP65).
Maltese: Purevax Rabies huwa vaċċin li fih virus rikombinanti tar-rabbja canarypox (vCP65).
English: This summary was last updated on 18.02.2011.
Maltese: Dan is-sommarju ġie aġġornat l-aħħar fi 18-02-2011.
English: Other information about Purevax Rabies:
Maltese: Informazzjoni oħra dwar Purevax Rabies:
English: The vaccine strain vCP65 in Purevax Rabies is a ‘carrier' canarypox virus that has been given a gene that makes it able to produce part of a rabies virus called ‘glycoprotein G'.
Maltese: Ir-razza tal-vaċċin vCP65 fi Purevax Rabies hija virus talcanarypox ‘ġarrier' li ngħata ġene li jagħmlu kapaċi jipproduċi parti minn virus tar-rabbja msejjaħ ‘glikoproteina G'.
English: The CVMP concluded that the benefits of Purevax Rabies outweigh the risks for the active immunisation of cats 12 weeks of age and older to prevent mortality due to rabies infection, and recommended that Purevax Rabies be given a marketing authorisation.
Maltese: Is-CVMP kkonkluda li l-benefiċċji ta' Purevax Rabies huma akbar mir-riskji għat-tilqim attiv ta' qtates li għandhom 12-il ġimgħa u aktar għall-prevenzjoni tal-mortalità minħabba infezzjoni tar-rabbja, u rrakkomanda li Purevax Rabies jingħata awtorizzazzjoni għat-tqegħid fis-suq.
English: Purevax Rabies is a liquid suspension for injection.
Maltese: Purevax Rabies huwa sospensjoni likwida għall-injezzjoni.
English: If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).
Maltese: Jekk tixtieq aktar informazzjoni abbażi tar-rakkomandazzjonijiet tas-CVMP, aqra ddiskussjoni xjentifika (hija parti wkoll mill-EPAR).
English: Occasionally, cats will develop temporary slight apathy (loss of interest in surroundings) and mild anorexia (loss of appetite) or hyperthermia (elevated body temperature) lasting for one or two days.
Maltese: Xi drabi, il-qtates jiżviluppaw xi apatija temporanja (nuqqas ta' interess fl-ambjent ta' madwarhom) u anoressija ħafifa (nuqqas ta' aptit) jew ipertermija (temperatura għolja tal-ġisem) li ddum jum jew tnejn.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Purevax Rabies to MERIAL on 18.02.2011.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida madwar l-Unjoni Ewropea kollha, għal Purevax Rabies lil MERIAL fil-18-02-2011.
English: The canarypox viruses do not spread or multiply in the cats but they do produce the glycoprotein G of the rabies virus.
Maltese: Il-virusis tal-canarypox ma jinfirxux jew jimmultipplikaw fil-qtates iżda fil-fatt jipproduċu l-glikoproteina G tal-virus tar-rabbja.
English: Why has Purevax Rabies been approved?
Maltese: Għaliex ġie approvat Purevax Rabies?
English: Purevax Rabies is used to vaccinate cats from 12 weeks of age to protect against rabies infection.
Maltese: Purevax Rabies jintuża għat-tilqim tal-qtates minn 12-il ġimgħa 'l fuq biex jiġu protetti kontra infezzjoni tar-rabbja.
English: A number of studies, including laboratory studies and field trials, were performed in kittens and cats looking at Purevax Rabies used either on its own or together with other cat vaccines, for primary and booster vaccination.
Maltese: Numru ta' studji, inklużi studji fil-laboratorju u provi kliniċi fuq il-post, saru fil-qtates frieħ u adulti fejn Purevax Rabies ġie studjat meta ntuża jew waħdu jew flimkien ma' vaċċini oħra tal-qtates, għat-tilqim primarju jew booster.
English: What is Purevax Rabies?
Maltese: X'inhu Purevax Rabies?
English: For a full list of the side-effects reported with Purevax Rabies, see the package leaflet.
Maltese: Għal-lista sħiħa ta' effetti sekondarji rrapportati b'Purevax Rabies, ara l-Fuljett ta' Tagħrif.
English: The laboratory studies showed that Purevax Rabies can give protection against rabies, and that the protection lasts for up to a year.
Maltese: L-istudji fil-laboratorju wrew li Purevax Rabies jista' jkun ta' protezzjoni kontra r-rabbja, u li lprotezzjoni ddum sa sena.
English: When a cat is given the vaccine, the immune system recognises the rabies glycoprotein G as ‘foreign' and makes antibodies against it.
Maltese: Meta qattus jingħata l-vaċċin, is-sistema immunitarja tagħraf lill-glikoproteina G tar-rabbja bħala ‘barranija' u tipproduċi antikorpi kontriha.
English: A 1 ml dose of Purevax Rabies is injected under the skin.
Maltese: Doża ta' 1 ml ta' Purevax Rabies tiġi injettata taħt il-ġilda.
English: What is the risk associated with Purevax Rabies?
Maltese: X'inhuwa r-riskju assoċjat ma' Purevax Rabies?
English: The first injection should be given in cats aged at least 12 weeks.
Maltese: L-ewwel injezzjoni għandha tingħata filqtates li għandhom mill-inqas 12-il ġimgħa.
English: The benefit-risk balance may be found in the scientific discussion module of this EPAR.
Maltese: Il-bilanċ benefiċċju-riskju jinsab fil-modulu tad-diskussjoni xjentifika ta' dan l-EPAR.
English: Canarypox recombinants such as those contained in Purevax Rabies are known to be safe for humans.
Maltese: Rikombinanti tal-canarypox bħal dawk li jinsabu fi Purevax Rabies huma magħrufin li huma siguri għall-bnedmin.
English: Age < 50 years ≥ 50 years
Maltese: Età < 50 sena ≥ 50 sena
English: Lidocaine (systemic)
Maltese: Lidocaine (sistemiku)
English: Primary PI/DRV
Maltese: PI/DRV Primarji
English: 6 cells/mm 3).
Maltese: 6 ċellula/mm 3).
English: ANTACIDS Aluminium/magnesium hydroxide
Maltese: ANTAĊIDI Aluminium/magnesium hydroxide
English: 3 (range:
Maltese: 3 (firxa:
English: Amiodarone Dronedarone Ivabradine Quinidine Ranolazine
Maltese: Dronedarone Ivabradine Quinidine Ranolazine
English: Total cholesterol (mmol/L) LDL cholesterol (mmol/L) HDL cholesterol (mmol/L) Triglycerides (mmol/L)
Maltese: Total ta' kolesterol (mmol/L) Kolesterol LDL (mmol/L) Kolesterol HDL (mmol/L) Trigliċeridi (mmol/L)
English: Poly (vinyl alcohol)- partially hydrolysed Talc
Maltese: Poly (vinyl alcohol)- parzjalment idrolizzat Talc
English: ANTIFUNGALS Clotrimazole Fluconazole Itraconazole
Maltese: ANTIFUNGALI Clotrimazole Fluconazole Itraconazole
English: EU/1/17/1225/001- 30 film-coated tablets EU/1/17/1225/002- 90 film-coated tablets (3 x 30)
Maltese: EU/1/17/1225/001- 30 pillola miksija b'rita EU/1/17/1225/002- 90 pillola miksija b'rita (3 x 30)
English: Via C. Janssen, Borgo San Michele
Maltese: Janssen, Borgo San Michele
English: CORTICOSTEROIDS Budesonide
Maltese: KORTIKOSTEROJDI Budesonide
English: simvastatin, lovastatin and lomitapide (see section 4.5) - dabigatran, ticagrelor
Maltese: simvastatin, lovastatin u lomitapide (ara sezzjoni 4.5) - dabigatran, ticagrelor
English: Darunavir After a 400/100 mg [
Maltese: Darunavir Wara doża ta' 400/100 mg darunavir [
English: It is not an inhibitor of CYP3A4 in vivo.
Maltese: Huwa mhuwiex inibitur ta' CYP3A4 in vivo.
English: ANTIBIOTIC Clarithromycin
Maltese: ANTIBIJOTIKU Clarithromycin
English: The absolute bioavailability of the emtricitabine 200 mg capsule was 93%.
Maltese: Il-bijodisponibbiltà assoluta tal-kapsula ta' 200 mg ta' emtricitabine kienet 93%.
English: HMG CO-A REDUCTASE INHIBITORS Atorvastatin
Maltese: INIBITURI TA' HMG CO-A REDUCTASE Atorvastatin
English: - Atorvastatin, fluvastatin, pitavastatin, pravastatin, rosuvastatin (to lower cholesterol levels).
Maltese: - Atorvastatin, fluvastatin, pitavastatin, pravastatin, rosuvastatin (biex ibaxxu l-livelli tal kolesterol).
English: - Budesonide, fluticasone (to control asthma).
Maltese: - Budesonide, fluticasone (biex jikkontrollaw l-ażma).
English: * DRV-RAMs: V11I, V32I, L33F, I47V, I50V, I54M, I54L, T74P, L76V, I84V, L89V.
Maltese: V11I, V32I, L33F, I47V, I50V, I54M, I54L, T74P, L76V, I84V, L89V.
English: 95-1,110), and median CD4+ % was 23% (range: 7-45%).
Maltese: 95-1,110), u l-medjan tal-% ta' CD4+ kien 23% (firxa: 7-45%).
English: ANTIMALARIALS Artemether/Lumefantrine
Maltese: MEDIĊINI KONTRA L-MALARJA Artemether/Lumefantrine
English: ANTICONVULSANTS Carbamazepine Phenobarbital Phenytoin
Maltese: ANTIKONVULŻIVI Carbamazepine Phenobarbital Phenytoin
English: Virologic Failure
Maltese: Falliment Viroloġiku
English: Rosuvastatin (10 mg once daily): rosuvastatin AUC ↑ 93% rosuvastatin Cmax ↑ 277% rosuvastatin Cmin ND
Maltese: Rosuvastatin (10 mg darba kuljum): rosuvastatin AUC ↑ 93% rosuvastatin Cmax ↑ 277% rosuvastatin Cmin ND
English: Treatment difference
Maltese: Differenza tat-Trattament
English: Atorvastatin (10 mg once daily): atorvastatin AUC ↑ 290% atorvastatin Cmax ↑ 319% atorvastatin Cmin ND
Maltese: Atorvastatin (10 mg darba kuljum): atorvastatin AUC ↑ 290% atorvastatin Cmax ↑ 319% atorvastatin Cmin ND
English: Week 96* D/C/F/TAF
Maltese: Ġimgħa 96* D/C/F/TAF
English: St. John's wort (Hypericum perforatum)
Maltese: John's wort (Hypericum Perforatum)
English: Based on theoretical considerations
Maltese: Abbażi ta' konsiderazzjonijiet teoretiċi
English: 6 cells/L (range 38 - 1,456 x 10
Maltese: 6 ċelluli/L (firxa minn 38 - 1,456 x 10
English: Each bottle contains 30 tablets.
Maltese: Kull flixkun fih 30 pillola.
English: Week 48 D/C + F/TDF
Maltese: Ġimgħa 48 D/C + F/TDF
English: However, unbound darunavir concentrations were approximately 55% (Child-Pugh Class A) and 100% (Child-Pugh Class B) higher, respectively.
Maltese: Madankollu, konċentrazzjonijiet ta' darunavir mhux marbut kienu madwar 55% (Klassi A ta' Child-Pugh) u 100% (Klassi B ta' Child-Pugh) ogħla, rispettivament.
English: UROLOGICAL DRUGS Fesoterodine Solifenacin
Maltese: MEDIĊINI UROLOĠIĊI Fesoterodine Solifenacin
English: No emergent resistance to E/C/F/TAF (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) was detected through Week 48.
Maltese: Ma ġiet innutata l-ebda reżistenza għal E/C/F/TAF (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) sa Ġimgħa 48.
English: Baseline viral load ≤ 100,000 copies/mL > 100,000 copies/mL
Maltese: Ammont virali fil-linja bażi ≤ 100,000 kopja/mL > 100, 000 kopja/mL
English: Cobicistat inhibits the transporters p-glycoprotein (P-gp), BCRP, MATE1, OATP1B1 and OATP1B3.
Maltese: Cobicistat jinibixxi ttrasportaturi glikoproteina p (P-gp, p-glycoprotein), BCRP, MATE1, OATP1B1 u OATP1B3.
English: Midazolam (parenteral) Zolpidem
Maltese: Midazolam (mill-vini) Zolpidem
English: - Digoxin (to treat certain heart disorders) - Clarithromycin (antibiotic) - Clotrimazole, fluconazole, Isavuconazole, itraconazole, posaconazole, (for treating fungal infections).
Maltese: - Digoxin (biex jitratta ċerti disturbi tal-qalb) - Clarithromycin (antibijotiku) - Clotrimazole, fluconazole, Isavuconazole, itraconazole, posaconazole, (biex jiġu ttrattati infezzjonijiet bil-fungi).
English: Marketing Authorisation Holder Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium
Maltese: Detentur tal-Awtorizzazzjoni għat-Tqegħid fis-Suq Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Il-Belġju
English: Tenofovir alafenamide is active against hepatitis B virus (HBV).
Maltese: Tenofovir alafenamide huwa attiv kontra l-virus talepatite B (HBV, hepatitis B virus).
English: There are pharmacokinetic data for the (individual) components of Symtuza.
Maltese: Hemm dejta farmakokinetika għallkomponenti (individwali) ta' Symtuza.
English: Tenofovir alafenamide is minimally metabolised by CYP3A4.
Maltese: Tenofovir alafenamide jiġi metabolizzat b'mod minimu minn CYP3A4.
English: C]-cobicistat, 86% and 8.2% of the dose were recovered in feces and urine, respectively.
Maltese: C], 86% u 8.2% tad-doża ġiet irkuprata fl-ippurgar u fl-awrina, rispettivament.
English: Overall, 22% had baseline plasma HIV-1 RNA > 100,000 copies/mL.
Maltese: Globalment, 22% kellhom RNA ta' HIV-1 ta' > 100,000 kopja/mL fil-plażma.
English: - Fesoterodine, solifenacin (to treat urologic disorders).
Maltese: - Fesoterodine, solifenacin (biex jittrattaw disturbi uroloġiċi).
English: 6 cells/L),
Maltese: 6 ċelluli/L), rispettivament.
English: • darunavir, an anti-HIV medicine known as a protease inhibitor
Maltese: • darunavir, mediċina kontra l-HIV magħrufa bħala inibitur tal-protease
English: Darunavir binds primarily to plasma α1-acid glycoprotein.
Maltese: Darunavir jintrabat primarjament mal-glikoproteina α1-acid tal-plażma.
English: Maximum plasma concentrations of darunavir, cobicistat, emtricitabine and tenofovir alafenamide were achieved at 4.00, 4.00, 2.00, and 1.50 hours after dosing, respectively.
Maltese: Il-konċentrazzjonijiet massimi ta' darunavir, cobicistat, emtricitabine u tenofovir alafenamide filplażma nkisbu 4.00, 4.00, 2.00, u 1.50 siegħa wara l-għoti tad-doża, rispettivament.
English: The active substances are darunavir, cobicistat, emtricitabine, and tenofovir alafenamide.
Maltese: Is-sustanzi attivi huma darunavir, cobicistat, emtricitabine, u tenofovir alafenamide.
English: Midazolam (oral) Triazolam
Maltese: Midazolam (mill-ħalq) Triazolam
English: Tenofovir alafenamide is a substrate of OATP1B1 and OATP1B3 in vitro.
Maltese: Tenofovir alafenamide huwa sustrat għal OATP1B1 u OATP1B3 in vitro.
English: Total Phase 3
Maltese: Fażi totali 3
English: The film-coating contains polyethylene glycol (macrogol), polyvinyl alcohol (partially hydrolyzed), talc, titanium dioxide and yellow ferric oxide.
Maltese: Il-kisja tar-rita fiha polyethylene glycol (macrogol), polyvinyl alcohol (parzjalment idrolizzat), talc, titanium dioxide u ferric oxide isfar.
English: Croscarmellose sodium Magnesium stearate Cellulose, microcrystalline Silica, colloidal anhydrouse
Maltese: Qalba tal-pillola Croscarmellose sodium Magnesium stearate Cellulose, microcrystalline Silica, colloidal anhydrous
English: ANTIANGINA/ANTIARRHYTHMIC Disopyramide
Maltese: MEDIĊINI KONTRA L-ANĠINA/ANTIARRITMIĊI Disopyramide
English: Subjects with ≥1 emergent RAM, n (%) Protease
Maltese: Individwi li feġġitilhom RAM ≥1, n (%) Protease
English: The median change in eGFRCG was -5.5 mL/min with D/C/F/TAF and -12.0 mL/min with D/C+F/TDF (p < 0.001).
Maltese: Il-medjan ta' bidla fl-eGFRCG kien -5.5 mL/min b'D/C/F/TAF u -12.0 mL/min b'D/C+F/TDF (p < 0.001).
English: Difference in Proportions
Maltese: Differenza fil-Proporzjonijiet
English: The pharmacologically active metabolite, tenofovir diphosphate, has a half-life of 150-180 hours within PBMCs.
Maltese: Il-metabolit attiv b'mod farmakoloġiku, tenofovir diphosphate, għandu half-life ta' 150-180 siegħa fil-PBMCs.
English: The systemic clearance of emtricitabine averaged 307 mL/min.
Maltese: It-tneħħija sistemika ta' emtricitabine kellha medja ta' 307 mL/min.
English: Treatment group
Maltese: Grupp ta' Trattament
English: Symtuza is an antiretroviral medicine used to treat infection with human immunodeficiency virus 1 (HIV-1).
Maltese: Symtuza huwa mediċina antiretrovirali użata biex titratta infezzjoni bil-virus tal-immunodefiċjenza umana (HIV-1, human immunodeficiency virus 1).
English: Date of first authorisation: 21 September 2017
Maltese: Data tal-ewwel awtorizzazzjoni: 21 ta' Settembru 2017
English: - Clonazepam (to prevent seizures).
Maltese: - Clonazepam (biex jevita aċċessjonijiet).
English: Darunavir and cobicistat
Maltese: Darunavir u cobicistat
English: Tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor (NtRTI) and phosphonoamidate prodrug of tenofovir (2'-deoxyadenosine monophosphate analogue).
Maltese: Tenofovir alafenamide huwa inibitur nucleotide ta' reverse transcriptase (NtRTI, nucleotide reverse transcriptase inhibitor) u promediċina phosphonoamidate ta' tenofovir (analogu ta' 2'-deoxyadenosine monophosphate).
English: - Oestrogen-based hormonal contraceptives and hormone replacement therapy.
Maltese: - Kontraċettivi tal-ormoni abbażi tal-estroġen u terapija ta' sostituzzjoni tal-ormoni.
English: C]-darunavir with ritonavir dose, approximately 79.5% and 13.9% of the administered dose of [
Maltese: C] b'ritonavir, madwar 79.5% u 13.9% tad-doża mogħtija ta'
English: Sulphonamide allergy
Maltese: Allerġija għal sulphonamide
English: Based on theoretical consideration, St. John's wort may substantially decrease DRV/COBI (CYP3A4 induction) and TAF exposures.
Maltese: Abbażi ta' konsiderazzjoni teoretika, St.John's wort jista' jnaqqas b'mod sostanzjali lesponimenti għal DRV/COBI (induzzjoni ta' CYP3A4) u TAF.
English: The tablet core contains croscarmellose sodium, magnesium stearate, microcrystalline cellulose and colloidal silicon dioxide.
Maltese: Il-qalba tal-pillola fiha croscarmellose sodium, magnesium stearate, microcrystalline cellulose u colloidal silicon dioxide.
English: Drug-induced hepatitis (e.g. acute hepatitis, cytolytic hepatitis) has been reported with darunavir/ritonavir.
Maltese: Epatite kkaġunata mill-mediċina (eż. epatite akuta, epatite ċitolitika) ġiet irrappurtata b'darunavir/ritonavir.
English: PROTON PUMP INHIBITORS Dexlansoprazole
Maltese: TAL-POMPA TAL-PROTON Dexlansoprazole
English: Baseline CD4+ cell count < 200 cells/mm ≥ 200 cells/mm
Maltese: Għadd ta' ċelluli CD4+ fil-linja bażi < 200 ċellula/mm ≥ 200 ċellula/mm
English: Manufacturer Janssen-Cilag SpA, Via C. Janssen, Borgo San Michele, 04100 Latina, Italy
Maltese: Janssen, Borgo San Michele, 04100 Latina, L-Italja
English: Cmax, ng/mL AUC24h, ng.h/mL Cmin, ng/mL
Maltese: Cmax, ng/mL